James Cullen is Director of JOHNSON & JOHNSON. Currently has a direct ownership of 1,489 shares of JNJ, which is worth approximately $217,170. The most recent transaction as insider was on Sep 10, 2014, when has been sold 2,446 shares (Common Stock) at a price of $104.12 per share, resulting in proceeds of $254,678. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.49K
0% 3M change
0% 12M change
Total Value Held $217,170

JAMES CULLEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 10 2014
SELL
Open market or private sale
$254,678 $104.12 p/Share
2,446 Reduced 62.16%
1,489 Common Stock
May 07 2013
SELL
Open market or private sale
$420,937 $85.4 p/Share
4,929 Reduced 56.15%
3,849 Common Stock
Nov 12 2012
SELL
Exercise of conversion of derivative security
$409,868 $53.93 p/Share
7,600 Reduced 25.41%
22,304 Common Stock
Nov 12 2012
SELL
Open market or private sale
$968,830 $69.7 p/Share
13,900 Reduced 62.32%
8,404 Common Stock
Nov 12 2012
BUY
Exercise of conversion of derivative security
$328,860 $52.2 p/Share
6,300 Added 29.99%
14,704 Common Stock

Also insider at

KEYS
Keysight Technologies, Inc. Technology
AVGR
Avinger Inc Healthcare
JC

James Cullen

Director
New Brunswick, NJ

Track Institutional and Insider Activities on JNJ

Follow JOHNSON & JOHNSON and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ